A detailed history of London & Capital Asset Management LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, London & Capital Asset Management LTD holds 103,151 shares of NVO stock, worth $8.77 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
103,151
Previous 92,914 11.02%
Holding current value
$8.77 Million
Previous $13.3 Million 7.39%
% of portfolio
0.98%
Previous 1.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $1.22 Million - $1.49 Million
10,237 Added 11.02%
103,151 $12.3 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $11.4 Million - $13.6 Million
92,914 New
92,914 $13.3 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track London & Capital Asset Management LTD Portfolio

Follow London & Capital Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on London & Capital Asset Management LTD with notifications on news.